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Objectives This study sought to evaluate the safety and efﬁcacy of transradial versus transfemoral
access for coronary angiography and percutaneous coronary intervention in patients with a body
mass index 40 kg/m2.
ackground Coronary angiography is most commonly performed via femoral artery access;
owever, the optimal approach in extremely obese (EO) patients remains unclear.
ethods Between January 2007 and August 2010, a cohort of consecutive EO patients who under-
ent coronary angiography was identiﬁed in our center’s registry of angiography and percutaneous
oronary intervention procedures. Of 21,103 procedures, 564 (2.7%) were performed in unique EO
atients: 203 (36%) via the transradial approach; and 361 (64%) via the transfemoral approach.
esults The primary outcome, a combined endpoint of major bleeding, access site complications,
nd nonaccess site complications, occurred in 7.5% of the transfemoral group and 2.0% of the trans-
adial group (odds ratio [OR]: 0.30, 95% conﬁdence interval [CI]: 0.10 to 0.88, p  0.029), an end-
point driven by reductions in major bleeding (3.3% vs. 0.0%, OR: 0.12, 95% CI: 0 to 0.71, p  0.015),
as well as access site injuries (4.7% vs. 0.0%, OR: 0.08, 95% CI: 0 to 0.48, p  0.002). There were no
differences in nonaccess site complications (1.7% vs. 2.0%, OR: 1.50, 95% CI: 0.41 to 5.55), but trans-
radial access procedures were associated with an increase in procedure time and patient radiation
dose (p  0.05).
Conclusions Transfemoral access for coronary angiography and percutaneous coronary intervention
was associated with more bleeding and access site complications when compared with a transradial
approach. Important reductions in procedural associated morbidity may be possible with a transra-
dial approach in EO patients. (J Am Coll Cardiol Intv 2012;5:819–26) © 2012 by the American
College of Cardiology Foundation
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820The obesity epidemic is expected to increase dramatically
(1). As numerous studies link the degree of obesity to
cardiovascular risk factors as well as overall morbidity and
mortality, it is projected that coronary artery disease preva-
lence will continue to climb (2). The World Health Orga-
nization has classified obesity based on body mass index
(BMI) into 4 categories: 1) overweight (BMI 25 to 29.9
kg/m2); 2) obese class I (BMI 30 to 34.9 kg/m2); 3) obese
lass II (BMI 35 to 39.9 kg/m2); and 4) obese class III (BMI
40 kg/m2). The latter patients, those with a BMI 40
g/m2, have also been termed as having extreme obesity
(EO). EO patients represent 6% of the total U.S. popula-
tion and nearly 3% of the Canadian population, with recent
data suggesting that the prevalence of patients with EO is
increasing at a rate nearly twice as fast as that for other
obesity subgroups (3,4).
Coronary angiography remains the gold standard for
establishing the coronary anatomy. However, performing
angiography in patients with EO presents unique risks. For
example, the risk of major bleeding (5) and in-hospital
mortality (6) has been shown to
follow a U-shaped curve—class
I and II obesity conferring a
protective effect with an increase
in bleeding risk seen after the
BMI rises above 40. Whereas
modification to standard proto-
col (7) or utilizing a radial ap-
proach (8) have been suggested
in these high-risk patients, the
safety of angiography and percu-
taneous coronary intervention
(PCI) in a large cohort of EO
patients has yet to be estab-
lished. This is of particular importance in light of
growing evidence linking bleeding complications with
increased mortality (9). Given the paucity of data, we
chose to evaluate the safety of a transradial approach for
coronary angiography and PCI compared with the trans-
femoral approach in patients with EO.
Methods
Study design, data source, and patients. The University of
Ottawa Heart Institute (UOHI) is the tertiary cardiac care
center for a population of approximately 1.3 million resi-
dents of eastern Ontario, including a regionalized ST-
segment elevation myocardial infarction program (10).
Clinical and demographic data, including height and
weight, are collected on all patients undergoing coronary
angiography or PCI in the UOHI PCI registry. From
January 2007 to August 2010, 21,103 consecutive coronary
procedures were prospectively indexed in the UOHI an-
Abbreviations
and Acronyms
BMI  body mass index
CI  confidence interval
EO  extreme obesity
OR  odds ratio
PCI  percutaneous
coronary intervention
TIMI  Thrombolysis In
Myocardial Infarction
UOHI  University of Ottawa
Heart Institutegiography/PCI registry from which a cohort of patients witha BMI 40 kg/m2 was identified and included in the
nalysis.
Both the registry records and medical records were
eviewed by 2 individuals for extraction of data. Inclusion in
he analysis required a BMI 40 kg/m2 and either coronary
angiography or PCI being performed. Exclusion criteria
consisted of incomplete data for analyzing events, procedure
other than angiography or PCI (e.g., right heart catheter-
ization, percutaneous valve implantation, patent foramen
ovale closure), cardiac arrest with cardiopulmonary resuscitation in
the preceding 24 h, or cardiogenic shock on arrival to the
catheterization laboratory. Both femoral and radial proce-
dures were routinely performed using 6-F sheaths. Choice
of access site and use of larger sheaths were at the discretion
of the operator. Patients were included in groups based on
the first attempted access site. This study was reviewed and
approved by the UOHI institutional human research ethics
board and was deemed not to require informed consent.
Outcome measures and deﬁnitions. The primary outcome
f this study was a combined endpoint of bleeding, access
ite, and nonaccess site complications. Bleeding endpoints
omprised TIMI (Thrombolysis In Myocardial Infarction)
ajor, minor (11), or non-TIMI bleeding requiring blood
ransfusion. Briefly, TIMI major bleeds were defined as
ntracranial or 5 g/dl in hemoglobin or a hematocrit drop
f 15%. TIMI minor bleeds were observed blood loss with
3 g/dl drop in hemoglobin or a 10% decrease in
ematocrit or no observed blood loss with a 4 g/dl or a
rop by 12% in hematocrit. Vascular access site compli-
ations included surgical repair or intervention on the access
ite (including percutaneous injections), pseudoaneurysm
reated conservatively, or a large hematoma (documented as
5 cm). Nonaccess site complications included coronary
rtery dissection, coronary perforation, transient ischemic
ttack or cerebrovascular accident, and death during the
ndex hospitalization. Secondary outcomes included each of
he components of the primary endpoint. Procedural failure,
efined as a combined endpoint of access site crossover,
ailed coronary angiography, or failed target vessel revascu-
arization, was also assessed. Patient radiation exposure was
stimated by total fluoroscopy time (min) and measured
ose area product (Gycm2).
Statistical analysis. All continuous variables were described
as mean  SD with categorical variables described as
number (%). For patient and procedural characteristics,
categorical variables were compared by chi-square and
continuous variables by t test or Mann-Whitney rank sum
test as appropriate. Statistical significance was defined as a
p value 0.05.
For analysis of the primary and secondary outcomes,
multiple logistic regression was performed and odds
ratios (OR) with adjusted p values are reported. Variables
known or suspected to be associated with the outcomes
were assessed individually versus primary and secondary
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821outcomes, and those demonstrating association with p 
0.2 were included as candidate variables in regression
models. For the outcomes of TIMI bleeding and access
site complications, an incidence of 0% in the transradial
cohort necessitated the use of exact logistic regression to
estimate OR and confidence intervals (CI), as indicated
(12,13). Given the relatively small sample size and the
sparse number of outcomes for individual components of
the composite outcome, regression models included as
many of the covariates as possible in order of univariate
significance and stopped at the most fully adjusted model
that successfully converged. Analyses were conducted
using SAS software (version 9.2, SAS Institute, Cary,
North Carolina).
Results
Baseline characteristics. We identified 564 procedures that
were performed in unique EO patients between January
2007 and August 2010 that met inclusion criteria (Fig. 1).
Of this group, 203 (36.0%) underwent angiography via a
radial approach and 361 (64.0%) via a femoral approach.
Interestingly, patients with EO represented only 3.95% of
Total Proce
(Jan 1/07-Au
21,103
Femoral Approach 
18,579 (88%)  
13,399 - BMI<40  
4,788 - repeat procedure  
BMI > 40 Femoral 
361 
Charts Reviewed 
392 
2 – shock 
1 – cardiac arrest  
12 – lack electronic records  
6 – incorrect ht/wt (BMI<40) 
3 – PFO closure 
1 – coil embolization  
4 – right heart cath  
1 – ICD  
1 – failure to access entirely 
Figure 1. Study Flow
Procedures were retrospectively identiﬁed from July 1, 2007, to August 1, 2010
index 40 kg/m2, repeat procedures in a single patient, incorrect dimensions
phy and/or percutaneous coronary intervention. BMI  body mass index; ICD  impall patients referred for angiography. Baseline and proce-
dural characteristics are presented in Table 1. Basic demo-
graphic data were similar between the groups, with patients
in the radial arm having modestly higher BMI (47.3  5.9
kg/m2 vs. 44.0  4.5 kg/m2, p  0.001). Notably, patients
in the radial group also had higher rates of heparin use,
reflecting, in part, routine use of heparin for radial proce-
dures and higher rates of PCI being performed (32.5% of
cases in the radial arm vs. 23.5% in the femoral arm, p 
0.05).
Outcomes. The composite primary outcome of bleeding
complications, access site injury, or nonaccess site compli-
cations occurred in 2.0% of radial cases and 7.5% of cases in
the femoral group (OR: 0.30, 95% CI: 0.10 to 0.88, p 
0.029) (Table 2). This endpoint was primarily driven by
increased rates of bleeding complications (0.0% radial vs.
3.3% femoral; OR: 0.12, 95% CI: 0 to 0.71, p  0.015) and
access site injury (0.0% radial vs. 4.7% femoral; OR: 0.08,
95% CI: 0 to 0.48, p 0.002). Nonaccess site complications
did not differ significantly between the groups (Table 2).
Regarding significant clinical events, 2 patients in the
femoral group had emergency surgery for hemodynamically
significant bleeds, and 1 patient died because of an access
s  
) 
Radial Approach  
2,524 (12%) 
1,929 - BMI<40 
385 - repeat procedure  
BMI > 40 Radial 
203 
1 – shock 
1 – cardiac arrest  
2 – lack electronic records  
2 – unclear access site  
1 – incorrect ht/wt (BMI<40) 
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were grouped based on approach. Exclusion criteria included body mass
ed, lack of electronic records, and procedure other than coronary angiogra-dure
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822site hemorrhage before surgical intervention. In the radial
group, 1 case of aortic dissection was identified 7 days after
the angiogram and was successfully managed surgically.
Overall, a radial approach significantly reduced the inci-
dence of procedural-related morbidity in EO patients when
compared with a femoral approach for coronary angiogra-
Table 1. Baseline and Angiographic Characteristics
Characteristic
Femoral
(n  361)
Radial
(n  203) p Value
Demographics
Male 192 (53.2) 101 (49.8) NS
Age, yrs 58.4 10.7 56.4 9.9 NS
Height, m 1.66 0.12 1.67 0.11 NS
Weight, kg 121.4 18.6 132.8 24.0 0.001
BMI, kg/m2 44.0 4.5 47.3 5.9 0.001
Risk factors
Hypertension 289 (80.1) 158 (77.8) NS
Diabetes 195 (54.0) 127 (62.6) NS
Smoking 206 (57.1) 121 (59.6) NS
Hyperlipidemia 270 (74.8) 165 (81.2) NS
Medications
ACEI/ARB* 210 (78.1) 123 (77.8) NS
Beta-blocker* 223 (82.9) 117 (74.1) 0.05
Statin* 228 (84.8) 125 (79.1) NS
ASA* 246 (91.4) 151 (95.6) NS
Clopidogrel* 168 (62.5) 105 (66.5) NS
Glycoprotein IIb/IIIa inhibitors 11 (3.0) 2 (1.0) NS
Thrombolytics 10 (2.8) 8 (4.0) NS
Heparin 77 (21.3) 157 (77.3) 0.001
Bivalirudin 63 (17.5) 33 (16.3) NS
Creatinine 89.6 30.7 98.1 52.8 NS
Previous history
CVA 14 (3.9) 15 (7.4) NS
MI 48 (13.3) 47 (23.2) 0.01
PCI 51 (14.1) 41 (20.2) NS
CABG 35 (9.7) 6 (3.0) 0.01
Procedural characteristics
Procedure time, min 30.5 23.0 44.3 25.3 0.001
Fluoroscopy time, min 6.7 6.3 12.5 8.2 0.001
Contrast volume, ml 154.8 72.8 174.4 90.2 0.06
Use of closure device 5 (1.4) 0 (0) NS
Procedural outcomes
Coronary angiogram 276 (76.5) 137 (67.5) 0.05
Normal anatomy 83 (23.0) 50 (24.6) NS
CAD for medical management 116 (32.1) 59 (29.1) NS
Referred for CABG 37 (10.2) 20 (9.9) NS
Referred for staged PCI 40 (11.1) 8 (3.9) 0.01
Percutaneous coronary intervention 85 (23.5) 66 (32.5) 0.05
Values are n (%) or mean SD. *Data available for 269 femoral patients and 158 radial patients.
ACEI angiotensin-converting enzyme inhibitor; ARB angiotensin receptor blocker; ASA
acetylsalicylic acid; BMI  body mass index; CABG  coronary artery bypass graft; CAD 
coronary artery disease; CVA  cerebrovascular accident; MI  myocardial infarction;
PCI  percutaneous coronary intervention.phy or PCI.Combined procedural failures, which was an endpoint
composed of access site crossover, failure to complete angiog-
raphy requiring repeat angiography at another time, or failure
to complete target vessel revascularization, did not differ
between approaches (7.3% radial vs. 5.8% in the femoral, p 
0.05) (Fig. 2). However, transradial access did result in a
significantly longer procedure time (44.3  25.3 min vs.
30.5  23.0 min, p  0.001) and fluoroscopy time (12.5 
8.2 min vs. 6.7  6.3 min, p  0.001) (Table 1) with a
strong trend toward more contrast volume use (p  0.06).
The increased use of fluoroscopy resulted in greater radia-
tion exposure to the patient as estimated by the dose area
product (194.1  260.1 Gycm2 vs. 123.3  106.5 Gycm2,
p  0.001) (Fig. 2).
Angiography versus PCI. We next divided the groups into
oronary angiography alone or PCI alone to see whether
ifferences were attributable to either subgroup (Table 3).
iagnostic angiography alone comprised most procedures
73%) with femoral procedures having significantly shorter
rocedure (22.0  10.8 min vs. 35.7  17.3 min, p 
.001) and fluoroscopy time (4.9  4.3 min vs. 10.3  7.3
in, p  0.001). In the PCI subgroup, radial access did not
ignificantly lengthen procedure time but was accompanied
y modest increase in fluoroscopy time (12.8  8.1 min vs.
6.9  8.3 min, p  0.01). In either coronary angiography
r PCI alone, radial access was not associated with signifi-
antly more contrast use.
Table 2. Procedural Outcomes
Femoral
(n  361)
Radial
(n  203) OR (95% CI) p Value
Combined primary outcome 27 (7.5) 4 (2.0) 0.30 (0.10–0.88)* 0.029
Bleeding complications 12 (3.3) 0 (0) 0.12 (0–0.71) ‡† 0.015
TIMI major bleeding 3 (0.8) 0 (0)
TIMI minor bleeding 7 (1.9) 0 (0)
Bleeding requiring transfusion 2 (0.6) 0 (0)
Access site complications 17 (4.7) 0 (0) 0.08 (0–0.48)‡§ 0.002
Access site
surgery/intervention
6 (1.7) 0 (0)
Pseudoaneurysm 4 (1.1) 0 (0)
Hematoma 5 cm 7 (1.9) 0 (0)
Nonaccess site complications 6 (1.7) 4 (2.0) 1.50 (0.41–5.55)† 0.54
Coronary perforation 0 (0) 1 (0.5)
Coronary dissection 2 (0.6) 1 (0.5)
TIA/CVA 1 (0.3) 0 (0)
Death during hospitalization 3 (0.8) 1 (0.5)
Aortic dissection 0 (0) 1 (0.5)
Values are n (%). *Adjusted for age, sex, BMI, bivalirudin, glycoprotein IIb/IIIa. †Adjusted for age
and sex. ‡Exact logistic regression methodology used to calculate exact OR and 95% CI. §Ad-
justed for age, sex, smoking, and glycoprotein IIb/IIIa.
CI confidence interval; ORodds ratio; TIA transient ischemic attack; TIMI ThrombolysisIn Myocardial Infarction; other abbreviations as in Table 1.
a
o
O
D
p
F
c
m
e
s
i
c
e
c
a
b
m
p
I
r
w
r
R
v
a
t
v
g
i
a
oups.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 5 , N O . 8 , 2 0 1 2 Hibbert et al.
A U G U S T 2 0 1 2 : 8 1 9 – 2 6 Radial Versus Femoral Approach in Obese Patients
823Regarding the combined primary outcome, PCI ac-
counted for more complications than coronary angiography
did. In the PCI group, radial access was associated with only
a 4.5% complication rate compared with 14.1% in EO
patients in whom femoral access was pursued (OR: 0.29,
95% CI: 0.05 to 1.22, p  0.11). Similarly, in the coronary
ngiography group, there was a trend toward decreased risk
f adverse events in the radial access group (0.7% vs. 5.4%;
R: 0.15, 95% CI: 0.003 to 1.04, p  0.06).
iscussion
Our study is the first to our knowledge to examine the
influence of access site selection on bleeding, vascular, and
procedural complications following coronary angiography or
PCI in EO patients. Among this high-risk group, we
observed a significantly lower rate of bleeding complications
and access site injuries when a transradial approach was
used. Overall, the composite primary outcome was reduced
from 7.5% in the transfemoral group to 2.0% in the
transradial group, suggesting that using the radial artery
preferentially for access in as few as 18 EO patients may
prevent 1 serious adverse event.
Patients with EO represent a unique population because
they are difficult to evaluate by standard noninvasive testing
(14); they have more associated coronary artery disease risk
factors; and they have an increased risk of morbidity and
mortality from cardiac events (2). Moreover, their risk is
compounded at the time of coronary angiography and PCI
due to an increased risk of complications. In our study, PCI
via a transfemoral approach markedly increased the compli-
cation rate compared with the rate in patients in whom
transradial access was selected (14.5% vs. 4.5%, respec-
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Figure 2. Combined Procedural Failure and Radiation Exposure for Transra
(A) Rates of access site crossover, failed completion of angiography, failed targ
(B) Average dose area product (Gycm2) for the transfemoral and transradial grtively). This finding is not surprising as others have reported gBMI 40 kg/m2, transfemoral access, and transfusion are
otent predictors of adverse outcomes following PCI (15).
or example, Cox et al. (5) noted a bimodal U-shaped risk
urve for vascular complications in their cohort study, with
ild obesity (BMI 30 to 36 kg/m2) showing reductions in
complication rates that then increased at higher BMI.
Our study is the first to look exclusively at these higher risk
individuals (i.e., World Health Organization class III,
BMI 40 kg/m2) and contributes to the evidence that
mploying a radial approach in select high-risk patients,
uch as those with EO, may provide an opportunity to
mprove clinical outcomes.
The debate regarding the optimal vascular access site for
oronary angiography and PCI continues to be studied
xtensively, with proponents of radial angiography often
iting reductions in access site complications and bleeding
s a rationale for its use (16). Indeed, the association
etween bleeding complications, need for transfusion, and
ortality has been known to exist in myocardial infarction
atients undergoing revascularization for some time (17,18).
n a recent systematic review and meta-analysis of 23
andomized controlled trials, fewer bleeding complications
ere seen with radial access, leading to a trend toward
educed ischemic endpoints and death (19). By contrast, the
IVAL (Radial Versus Femoral Access for Coronary Inter-
ention) study, a large randomized trial of radial versus femoral
ccess, failed to significantly reduce death, myocardial infarc-
ion, or bleeding outcomes despite significant reductions in
ascular access complications (20). However, high-risk sub-
roups, such as patients with ST-segment elevation myocardial
nfarction, did show reductions in adverse events. Despite this
ccruing evidence, developing the required expertise and mar-
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824between 1% and 2% of all cases performed in the United States
and only 10% of cases in Canada (21,22).
The magnitude of benefit seen in our study (a 5.5%
absolute reduction in combined primary outcome) is similar
to the effect size seen in other bleeding reduction strategies
that have been more widely implemented. For example,
reductions in bleeding outcomes have led to the popular-
ization of agents such as fondaparinux and bivalirudin.
Notably, systematic reviews have repeatedly demonstrated
that transradial access in unselected populations for coro-
nary angiography results in approximately a 2.5% absolute
reduction in bleeding complications, similar to results
achieved in the OASIS 5 (Fifth Organization to Assess
Strategies in Acute Ischemic Syndromes) trial, the ACUITY
(Acute Catheterization and Urgent Intervention Triage
Strategy Trial), and HORIZONS-AMI (Harmonizing
Outcomes With Revascularization and Stents in Acute
Myocardial Infarction) trial (19,23,24). In high-risk popu-
lations, such as patients with EO, the magnitude of benefit
may be even larger. For example, reductions in adverse
Table 3. Angiography or PCI Procedural Characteristics and Outcomes
Angiography (n  413)
Femoral
(n  276)
Radial
(n  137) OR (95
Medications
Glycoprotein IIb/IIIa Inhibitors 0 (0) 1 (0.7)
Thrombolytics 0 (0) 1 (0.7)
Heparin 40 (14.5) 99 (72.3)
Bivalirudin 4 (1.4) 2 (1.5)
Procedural characteristics
Procedure time, min 22.0 10.8 35.7 17.3
Fluoroscopy time, min 4.9 4.3 10.3 7.3
Contrast volume, ml 131.3 50.2 134.8 60.6
Combined primary outcome 15 (5.4) 1 (0.7) 0.15 (0.003
Bleeding complications 8 (2.9) 0 (0) 0.17 (0.0–1
TIMI major bleeding 2 (0.7) 0 (0)
TIMI minor bleeding 4 (1.4) 0 (0)
Bleeding requiring transfusion 2 (0.7) 0 (0)
Access site complications 10 (3.6) 0 (0) 0.19 (0.0–1
Access site surgery/intervention 3 (1.1) 0 (0)
Pseudoaneurysm 3 (1.1) 0 (0)
Hematoma 5 cm 4 (1.4) 0 (0)
Nonaccess site complications 4 (1.4) 1 (0.7) 0.71 (0.01–
Coronary perforation 0 (0) 0 (0)
Coronary dissection 1 (0.4) 0 (0)
TIA/CVA 1 (0.4) 0 (0)
Death during hospitalization 2 (0.7) 1 (0.7)
Aortic dissection 0 (0) 0 (0)
Values are presented as n (%) ormean SD. *Adjusted for age and sex. †Adjusted for age and diabe
Adjusted for sex, diabetes status, and smoking. ¶Adjusted for age. #Adjusted for statin use and sm
Abbreviations as in Tables 1 and 2.events have been seen in octogenarians with a transradialapproach, resulting in a 5% absolute reduction in vascular
complications (25). Similar to our findings, patients in the
TROP (Transradial Approach in Overweight Patients)
registry with World Health Organization class II and III
obesity had a marked reduction in vascular complications
delaying hospital discharge (0.8 vs. 5.1%) in patients with a
BMI 35 when using a transradial approach (26). Thus, in
patients considered high risk for access site complications,
selecting a transradial approach for coronary angiography or
PCI may be the single most important intervention for
reducing procedural morbidity not currently being widely
employed.
Although important reductions in access site complica-
tions were achieved, transradial access in our study came at
a cost: namely increased procedure time and radiation
exposure to the patients. However, these findings are not
surprising given that transradial access (27) and patient size
(28) are known to contribute to increased radiation expo-
sure. Nonetheless, recent studies have demonstrated that
effective use of radiation shielding (29,30) and increased
PCI (n  151)
p Value
Femoral
(n  85)
Radial
(n  66) OR (95% CI) p Value
NS 11 (12.9) 1 (1.5) 0.02
NS 10 (11.8) 7 (10.6) NS
0.001 37 (43.5) 58 (87.9) 0.001
NS 59 (69.4) 31 (46.9) 0.01
0.001 57.7 29.7 61.0 29.9 NS
0.001 12.8 8.1 16.9 8.3 0.01
NS 232.8 81.5 256.1 86.7 0.09
* 0.06 12 (14.1) 3 (4.5) 0.29 (0.05–1.22)† 0.11
0.07 4 (4.7) 0 (0) 0.24 (0.0–1.93)‡§ 0.19
1 (1.2) 0 (0)
3 (3.5) 0 (0)
0 (0) 0 (0)
0.09 7 (8.2) 0 (0) 0.13 (0.0–0.86)‡§ 0.03
3 (3.5) 0 (0)
1 (1.2) 0 (0)
3 (3.5) 0 (0)
¶ 1.0 2 (2.4) 3 (4.5) 1.83 (0.19–24.4)‡# 0.86
0 (0) 1 (1.5)
1 (1.2) 1 (1.5)
0 (0) 0 (0)
1 (1.2) 0 (0)
0 (0) 1 (1.5)
us. ‡Exact logistic regressionmethodology used to calculate exact OR and 95%CI. §No adjustment.% CI)
–1.04)
.13)‡§
.24)‡
8.19)‡
tes stat
oking.operator experience (31) can markedly reduce radiation
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825exposure for the patient and operator alike. As well, Uhle-
mann et al. (32) recently demonstrated that radial artery
occlusion occurs in as many as 13.7% of patients with 5-F
systems and 30.5% of 6-F systems. In our cohort, no cases
of radial artery occlusion required surgical intervention nor
were any documented by imaging, which simply reflects the
lack of systematic evaluation of radial artery patency. None-
theless, this important complication limits repeat use of a
transradial approach and is an important consideration in
selecting the access site for future cardiac catheterizations.
Study limitations. The main limitation in our study is the
nonrandomized nature of the cohort study, thus we identi-
fied and adjusted for known confounding variables. How-
ever, the low number of endpoints observed in our study
(e.g., no bleeding or access site complications in the radial
group) necessitated the use of exact regression models that
may limit the precision of the effect estimates. We also
could not control for differences in skill of the operators. It
is conceivable that a radial approach may be preferentially
selected by more skilled angiographers. However, we can
report that all operators were represented in both groups
and perform vastly more procedures (i.e., minimum 75
annually) than the American Heart Association/American
College of Cardiology guidelines suggest; hence, operator
experience likely did not influence outcome. Another limi-
tation of our study is the low rate of percutaneous closure
device use, as is our institutional practice. A recent obser-
vational study (33) has suggested they may be associated
with lower rates of bleeding, but others have noted increased
risks of major bleeds and need for surgical repair following
closure device deployment. Indeed, a recent American
Heart Association scientific statement has recommended
against routine use, highlighting potential increased risks
(34,35).
Conclusions
Our analysis suggests that a radial approach for coronary
angiography and PCI in patients with EO can markedly
reduce bleeding and vascular access complications. In view
of the magnitude of the reduction in procedural morbidity,
a randomized controlled trial is needed in the EO popula-
tion to definitively establish impact on clinical outcomes.
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